Biocorp and Novo Nordisk join forces for digital diabetes health

Biocorp and Novo Nordisk are collaborating to develop and distribute a smart add-on device for the Novo Nordisk FlexTouch pen.

Mallya, a Bluetooth-enabled smart add-on device for pen injectors, collects the dose and time of each injection and transfers information in real-time to a companion software. Most Novo Nordisk’s insulins are offered with the FlexTouch pen, and a specific version of Mallya will be developed for it, the first prefilled insulin delivery device with no-push-button extension. Due to the unique dosing mechanism of FlexTouch, the push button does not extend at any dose and allows insulin to be administered by pressing the low injection force button. The current Mallya device required a redesign to meet the needs of this mechanism, keeping its accuracy and reliability.

Novo Nordisk plans to distribute the smart device in selected countries upon successful development, and Biocorp expects to ramp up production volumes from 2022.

Desang Diabetes Magazine is our free-to-receive digital journal (see below). We cover diabetes news, diabetes management equipment (diabetes ‘kit’ such as insulin pumps and continuous glucose monitoring equipment) and news about food suitable for a diabetic diet including a regular Making Carbs Count column. We just need your email address to subscribe you (it really is free, and you can easily unsubscribe should you wish to).
Sign me up!
Open publication
Buy a Desang kitbag

See our range of kitbags